In many cancer types, increased N-cadherin is shown to be correlated with tumor aggressiveness and lower survival rates, though the exact mechanisms of N-cadherin involvement in the above processes have not been clearly elucidated [83,84]. The gene discussed is CDH2; the disease is cancer.